• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶处理的人免疫球蛋白制剂各成分的C1q和C3bi结合活性

C1q and C3bi binding activities of the components of a plasmin-treated human immunoglobulin preparation.

作者信息

Masuda K

出版信息

Jpn J Med Sci Biol. 1983 Feb;36(1):39-41. doi: 10.7883/yoken1952.36.39.

DOI:10.7883/yoken1952.36.39
PMID:6223166
Abstract

Each of the three major components isolated from a commercial plasmin-treated human immunoglobulin preparation, namely, the plasmin-resistant 7S IgG fraction (PRG), Fab fragment and Fc fragment, was tested before and after heat treatment for binding C1q and fixing C3bi. In unheated state, only PRG was found to bind C1q, whereas none bound C3bi. The binding of C1q by PRG was enhanced by heat treatment which also conferred the activity of binding C3bi to PRG and to Fc fractions, From these results, anticomplementary activity of unheated PRG fraction seems to be due mainly to the complement activation via the classical pathway, whereas the activation by the heat-treated Fc fragment might be via an alternative pathway.

摘要

从市售的经纤溶酶处理的人免疫球蛋白制剂中分离出的三种主要成分,即抗纤溶酶的7S IgG组分(PRG)、Fab片段和Fc片段,在热处理前后均进行了结合C1q和固定C3bi的测试。在未加热状态下,仅发现PRG能结合C1q,而没有一种能结合C3bi。热处理增强了PRG对C1q的结合能力,同时也赋予了PRG和Fc组分结合C3bi的活性。根据这些结果,未加热的PRG组分的抗补体活性似乎主要归因于通过经典途径的补体激活,而热处理后的Fc片段的激活可能是通过替代途径。

相似文献

1
C1q and C3bi binding activities of the components of a plasmin-treated human immunoglobulin preparation.纤溶酶处理的人免疫球蛋白制剂各成分的C1q和C3bi结合活性
Jpn J Med Sci Biol. 1983 Feb;36(1):39-41. doi: 10.7883/yoken1952.36.39.
2
Anticomplementary properties of plasmin-treated human G immunoglobulin and its components.纤溶酶处理的人G免疫球蛋白及其组分的抗补体特性。
Int Arch Allergy Appl Immunol. 1978;57(4):315-8.
3
Antibody spectrum and anticomplementary activity of a plasmin-treated human immunoglobulin preparation.纤溶酶处理的人免疫球蛋白制剂的抗体谱及抗补体活性
Vox Sang. 1982 Jan;42(1):8-15. doi: 10.1111/j.1423-0410.1982.tb01064.x.
4
Regulation of the alternative pathway of human complement by C1q.
Mol Immunol. 1987 Sep;24(9):987-93. doi: 10.1016/0161-5890(87)90011-3.
5
Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A.静脉注射用各种免疫球蛋白制剂的特性。II. 补体激活及与葡萄球菌蛋白A的结合
Vox Sang. 1982 Feb;42(2):74-80. doi: 10.1159/000460851.
6
The interaction of immune serum globulin and immune globulin intravenous with complement.免疫血清球蛋白与静脉注射免疫球蛋白与补体的相互作用。
Mol Immunol. 1983 Aug;20(8):893-900. doi: 10.1016/0161-5890(83)90087-1.
7
C1 activation by immunoglobulin and immunoglobulin antibodies.
Biochem Soc Trans. 1984 Oct;12(5):738-9. doi: 10.1042/bst0120738.
8
Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.针对补体亚成分C1q不同结构域的单克隆抗体对人补体第一成分C1的激活作用。
J Immunol. 1986 Jul 1;137(1):255-62.
9
[Studies on the properties of the component of plasmin-treated IgG and the relation between IgG aggregates and complement-fixing ability (author's transl)].纤溶酶处理的IgG成分特性及IgG聚集体与补体结合能力关系的研究(作者译)
Hokkaido Igaku Zasshi. 1974 Nov;49(6):522-35.
10
Complement interaction with immune serum globulin and immune globulin intravenous.
Am J Med. 1984 Mar 30;76(3A):19-24. doi: 10.1016/0002-9343(84)90315-2.